Gastroenterology
Volume 133, Issue 3 , Pages 825-834 , September 2007

Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-analysis of Individual Patient Data

  • Francesco Salerno

      Affiliations

    • Department of Internal Medicine, IRCCS Policlinico San Donato, University of Milan, Milan, Italy
    • Corresponding Author InformationAddress requests for reprints to: Francesco Salerno, MD, Dipartimento di Medicina Interna, IRCCS Policlinico San Donato, Università di Milano, Via Morandi 30, 20097 San Donato Milanese, Italy. fax: (39) 0252774462.
    • ,
  • Calogero Cammà

      Affiliations

    • Cattedra e Unità Operativa di Gastroenterologia, University of Palermo, Palermo, Italy
    • IBIM, Consiglio Nazionale delle Ricerche, Palermo, Italy
    • ,
  • Marco Enea

      Affiliations

    • Cattedra e Unità Operativa di Gastroenterologia, University of Palermo, Palermo, Italy
    • IBIM, Consiglio Nazionale delle Ricerche, Palermo, Italy
    • ,
  • Martin Rössle

      Affiliations

    • Department of Medicine, Albert Ludwig University, Freiburg, Germany
    • ,
  • Florence Wong

      Affiliations

    • Department of Medicine, Division of Gastroenterology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada

Received 29 December 2006 ,Accepted 31 May 2007.

References 

  1. Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis (International Ascites Club). Hepatology. 1996;23:164–176
  2. Epstein M. Treatment of refractory ascites. N Engl J Med. 1989;321:1675–1677
  3. Guardiola J, Xiol X, Escriba JM, et al. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt. Am J Gastroenterol. 1995;90:2097–2102
  4. Ginès P, Guevara M, Arroyo V, et al. Hepatorenal syndrome. Lancet. 2003;362:1819–1827
  5. Moore KW, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2004;38:258–266
  6. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med. 1995;332:1192–1197
  7. Quiroga J, Sangro B, Nuñez M, et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology. 1995;21:986–994
  8. Forrest EH, Stanley AJ, Redhead DN, et al. Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis. Aliment Pharmacol Ther. 1996;10:801–806
  9. Najarian GK, Bjarnason H, Dietz CA, et al. Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology. 1997;205:173–180
  10. Lebrec D, Giuily N, Hadengue A, et al. Transjugular intrahepatic portosystemic shunt: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol. 1996;25:135–144
  11. Rössle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000;342:1701–1707
  12. Ginès P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology. 2002;123:1839–1847
  13. Sanyal AJ, Genning C, Reddy KR, et al. The North American Study for the treatment of refractory ascites. Gastroenterology. 2003;124:634–641
  14. Salerno F, Merli M, Riggio O, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology. 2004;40:629–635
  15. Albillos A, Banares R, Gonzalez M, et al. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol. 2005;43:990–996
  16. D’Amico G, Luca A, Morabito A, et al. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology. 2005;129:1282–1293
  17. Saab S, Nieto JM, Ly D, et al. TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane Database Syst Rev. 2004;3:CD004889
  18. Early Breast Cancer Trialists’ Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet. 1992;339:1–15
  19. Fine HA, Dear KB, Loeffler JS, et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 1993;71:2585–2597
  20. Conn HO, Libertal MM. The hepatic coma syndromes and lactulose. In: Baltimore, MD: Williams and Wilkins; 1979;p. 46–84
  21. SAS Technical Report (SAS/STAT software. Changes and enhancements, release 6.07). Cary, NC: SAS Institute, Inc; 1992;
  22. Allard JP, Chau J, Sandokji K, et al. Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites. Am J Gastroenterol. 2001;96:2442–2447
  23. Vale CL, Tierney JF, Stewart LA. Effects of adjusting for censoring on meta-analyses of time-to-event outcomes. Int J Epidemiol. 2002;31:107–111
  24. Jeng GT, Scott JR, Burmeister LF. A comparison of meta-analytic results using literature vs individual patient data (Paternal cell immunization for recurrent miscarriage). JAMA. 1995;274:830–836
  25. Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: is there a difference?. Lancet. 1993;341:418–422
  26. Deschenes M, Dufresne M, Bui B, et al. Predictors of clinical response to transjugular intrahepatic portosystemic hunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol. 1999;94:1361–1365
  27. Chalasani N, Scott Clark W, Martin LG, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology. 2000;118:138–144
  28. Borroni GM, Maggi A, Sangiovanni A, et al. Clinical relevance of hyponatremia for the hospital outcome of cirrhotic patients. Dig Liver Dis. 2000;32:605–610
  29. Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004;40:802–810
  30. Biggins BW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130:1652–1660
  31. Somberg KA, Riegler JL, LaBerge JM, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol. 1995;4:549–555
  32. Cabrera J, Maynard M, Granados R, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of hemorrhage. Gastroenterology. 1996;20:46–55
  33. Rössle M, Deibert P, Haag K, et al. Randomised trial of transjugular-intrahepatic- portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet. 1997;249;:1043–1049
  34. Sauer P, Theilmann L, Stremmel W, et al. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for rebleeding. Gastroenterology. 1997;113:1623–1631
  35. Nolte W, Wiltfang J, Schindler C, et al. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric and electroencephalographic investigations. Hepatology. 1998;28:1215–1225
  36. Hassoun Z, Deschenes M, Lafortune M, et al. Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy. Am J Gastroenterol. 2001;96:1205–1209
  37. Sanyal AJ, Freedman AM, Schiffman ML, et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology. 1994;20:46–55
  38. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53:1119–1129

 The current study was performed under the auspices of the International Club of Ascites (www.icascites.org).

 The authors report no conflict of interest.

PII: S0016-5085(07)01161-4

doi: 10.1053/j.gastro.2007.06.020

Gastroenterology
Volume 133, Issue 3 , Pages 825-834 , September 2007

Article Tools

* Image Usage & Resolution